ALDX — ALDEYRA THERAPEU

Ownership history in MARSHALL WACE, LLP  ·  7 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in ALDEYRA THERAPEU (ALDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2022 Q4)
Avg. % of fund
0.0%
First filed
2018 Q3
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 160,213 -23,124 -12.6% 0.00% $836K $5.22
2023 Q2 ADDED 183,337 +106,232 +137.8% 0.00% $1.5M $8.39
2023 Q1 REDUCED 77,105 -245,476 -76.1% 0.00% $766K $9.93
2022 Q4 ADDED 322,581 +122,418 +61.2% 0.01% $2.2M $6.96
2022 Q3 ADDED 200,163 +122,482 +157.7% 0.00% $1.1M $5.34
2022 Q2 ADDED 77,681 +61,846 +390.6% 0.00% $309K $3.99
2018 Q3 INITIATED 15,835 — — 0.00% $219K —
% of Fund (quarterly)    ALDX price (monthly, adj. close)

Other funds also holding ALDX

As of 2025 Q4 — sorted by position size

Knoll Capital Management, LLC 3Y 7Y 13.01% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 1.14% ARDSLEY ADVISORY PARTNERS LP 3Y 7Y 0.82% 1492 Capital Management LLC 3Y 7Y 0.44% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.39% 683 Capital Management, LLC 3Y 7Y 0.34% AlphaCentric Advisors LLC 3Y 0.18% Palo Alto Investors LP 3Y 7Y 0.16% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.14% WOODSTOCK CORP 3Y 7Y 0.12%
← Back to MARSHALL WACE, LLP Holdings